文献速递食管与纵隔外科

cT1bN0食管癌外科与内镜治疗的比较效果

Surgical and endoscopic management of clinical T1b esophageal cancer.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-06-24

该研究基于国家癌症数据库2010-2018年1469例cT1bN0食管癌患者,比较食管切除术(926例)与内镜治疗(543例)的效果。淋巴结升级与淋巴血管侵犯(OR 6.88)、低分化(OR 2.77)和肿瘤>1cm(OR 3.19)相关。倾向匹配后食管切除术5年生存率68.4% vs 内镜59.7%(P<.001),但高分化肿瘤两种治疗生存相似。

要点

  • cT1bN0食管癌淋巴结升级与淋巴血管侵犯、低分化和肿瘤>1cm相关
  • 倾向匹配后食管切除术5年生存率68.4% vs 内镜59.7%(P<.001)
  • 高分化肿瘤患者手术与内镜治疗生存相似

核心结论

  • 食管切除术与cT1bN0食管癌生存改善相关,但 favorable 肿瘤特征患者内镜治疗可能获得相似生存。

研究设计与样本

  • 基于国家癌症数据库的回顾性队列研究,纳入2010-2018年1469例cT1bN0食管癌患者,926例接受食管切除术,543例接受内镜治疗。

主要发现

  • 内镜治疗患者较食管切除术患者年龄更大(中位71岁,IQR 63-78 vs 66岁,IQR 60-72,P<.0001)且肿瘤更小。
  • 倾向匹配后食管切除术组5年总生存率68.4% vs 内镜组59.7%(P<.001)。
  • 加速时间失败模型提示高分化肿瘤患者手术与内镜治疗结局相似。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Esophageal cancers that invade the submucosa (T1b) have increased risk for occult lymph node metastases. To avoid the morbidity and recovery from esophagectomy, patients with cT1bN0 tumors have been increasingly managed endoscopically. We hypothesized that tumor attributes could predict upstaging and outcome associated with surgical and endoscopic treatment. Our objective was to evaluate the comparative effectiveness of esophagectomy across different cT1bN0 tumor attributes. METHODS: Treatment-naïve patients who underwent endoscopic management or esophagectomy for a clinical stage cT1bN0 esophageal cancer diagnosed between 2010 and 2018 in the National Cancer Database were identified. Factors associated with upstaging were assessed by logistic regression. Adjusted survival was assessed by Kaplan-Meier analysis of 528 propensity-matched pairs and accelerated time failure models, stratified across tumor attributes. RESULTS: Overall, 1469 patients classified as cT1bN0 were identified; 926 underwent esophagectomy and 543 were managed endoscopically. In general, patients who were managed endoscopically were older (median, 71; interquartile range, 63-78; vs 66; interquartile range, 60-72; P < .0001) with smaller tumors compared with the patients who were managed with esophagectomy. Nodal upstaging was associated with lymphovascular invasion (odds ratio [OR], 6.88; confidence interval [CI], 4.39-10.77; P < .0001), poor tumor differentiation (OR, 2.77; CI, 1.30-5.88; P = .0081), and tumor size >1 cm (OR, 3.19; CI, 1.49-6.83, P = .0028). Overall survival was better among propensity-matched patients who underwent esophagectomy (5-year 68.4% vs 59.7% endoscopic, P < .001). However, accelerated time failure models suggested similar outcomes among patients with well-differentiated tumors managed surgically or endoscopically. CONCLUSIONS: Esophagectomy was associated with improved survival for cT1bN0 esophageal cancer; however, endoscopic treatment may achieve similar survival in patients with favorable tumor attributes. Further study is warranted.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ayoade OF, Canavan ME, De Santis WP, et al. Surgical and endoscopic management of clinical T1b esophageal cancer. J Thorac Cardiovasc Surg. 2024. PMID: 38925509. doi:10.1016/j.jtcvs.2024.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。